NVO (NYSE) - Novo Nordisk A/S

Exchange: USA Stocks • Country: Denmark • Currency: USD • Type: Common Stock • ISIN: US6701002056
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Web URL: https://www.novonordisk.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for NVO (NYSE) - Novo Nordisk A/S
  • Uncommon Growth Rate


Market Cap in USD 446,463m
Sector Healthcare
Industry Biotechnology
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 1982-01-04


Fundamental 9.14
Dividend 8.89
Performance 5y 9.40
Rel. Performance vs Sector 1.56
Analysts 3.75
Fair Price Total Ret. 110.69
Fair Price DCF todo


Growth TTM 94.75%
CAGR 5y 35.19%
CAGR / Mean Drawdown 5y 7.18
Sharpe Ratio TTM 2.99
Alpha vs SP500 TTM 81.77
Beta vs SP500 5y weekly 0.68
CAPM 6.83%
Average Daily Range 2m 1.81%
Reversal Oscillator 14.93
Volatility GJR Garch 1y 25.42%
Price / SMA 50 2.21%
Price / SMA 200 16.96%
Current Volume 2940k
Average Volume 20d 4439k


Yield TTM 2.24%
Yield on Cost 5y 10.08%
Dividends CAGR 5y 23.84%
Consistency of Dividends all time 85.2%